Synergistic effects of pravastatin and pioglitazone in renal tubular epithelial cells induced by transforming growth factor‐β1
Authors:
- 1 May 2007
- journal article
- Published by Wiley in Cell Biology International
- Vol. 31 (5) , 451-458
Abstract
Recent studies suggest that treatment with PPAR-gamma agonists and statins have beneficial effects on renal disease. However, the combined effects of PPAR-gamma agonists and statins in human renal epithelial cells are unknown. Our present study revealed that there were synergistic effects of pravastatin and pioglitazone in the expression of alpha-smooth muscle actin (alpha-SMA), connective tissue growth factor (CTGF), fibronectin (FN), plasminogen activator inhibitor-1 (PAI-1) and collagen 1 in human renal proximal tubular epithelial cells induced by transforming growth factor-beta 1 (TGF-beta1). The beneficial effects of combined therapy against renal tubular epithelial cell injury are attributed, at least in part, to the inhibition of transdifferentiation, extracellular matrix deposition and cytokine production.Keywords
This publication has 53 references indexed in Scilit:
- Rosiglitazone ameliorates cisplatin-induced renal injury in miceNephrology Dialysis Transplantation, 2006
- PPAR-α and -γ agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouseNephrology Dialysis Transplantation, 2006
- Aldosterone Activates Vascular p38MAP Kinase and NADPH Oxidase Via c-SrcHypertension, 2005
- Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic responsesKidney International, 2004
- Pravastatin up-regulates transforming growth factor-β1 in THP-1 human macrophages: effect on scavenger receptor class A expressionBiochemical and Biophysical Research Communications, 2004
- Lipaemia, Inflammation and AtherosclerosisDrugs, 2004
- Role of mitogen-activated protein kinases as downstream effectors of transforming growth factor-β in mesangial cellsKidney International, 2000
- Effect of pravastatin on type IV collagen secretion and mesangial cell proliferationKidney International, 1999
- Effect of lipid-lowering strategies on tubular cell biologyKidney International, 1999
- Regulation of the mevalonate pathwayNature, 1990